Diagnostik und Therapie bei schwer einstellbarer Hypertonie

Schlüsselwörter

schwer einstellbare Hypertonie - Non-Compliance - sekundäre Hypertonieformen

Keywords

resistant hypertension - non-compliance - secondary hypertension

Literatur

• 1 Anderson Jr G H, Blakeman N, Streeten D H. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients.  J Hypertens. 1994;  12 609-15
• 2 Berlowitz D R, Ash A S, Hickey E C, Friedman R H, Glickman M, Kader B, Moskowitz M A. et al . Inadequate management of blood pressure in a hypertensive population.  N Engl J Med. 1998;  339 1957-63
• 3 Brown M A, Buddle M L, Martin A. Is resistant hypertension really resistant?.  Am J Hypertens. 2001;  14 1263-9
• 4 Calhoun D A, Jones D, Textor S, Goff D C, Murphy T P, Toto R D, White A, Cushman W C, White W, Sica D, Ferdinand K, Giles T D, Falkner B, Carey R M. American Heart Association Professional Education Committee . Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.  Circulation. 2008;  117 e510-26
• 5 Chobanian A V, Bakris G L, Black H R, Cushman W C, Green L A, Izzo Jr J L, Jones D W, Materson B J, Oparil S, Wright Jr J T, Roccella E J. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: the JNC 7 report.  JAMA. 2003;  289 2560-72
• 6 Cuspidi C, Macca G, Sampieri L. et al . High prevalence of cardiac and extracardiac organ damage in refractory hypertension.  J Hypertens. 2001;  19 2063-70
• 7 Dickerson J EC, Hingorani A D, Ashby M J, Palmer C R, Brown M J. Optimisation of antihypertensive treatment by crossover rotation of four major classes.  Lancet. 1999;  353 2008-13
• 8 Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England. Results from the Health Survey for England 2006.  Hypertension. 2009;  53 480-6
• 9 Gonzaga C C, Calhoun D A. Resistant hypertension and hyperaldosteronism.  Curr Hypertens Rep. 2008;  10 496-503
• 10 Hajjar I, Kotchen T A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1998 – 2000.  JAMA. 2003;  290 199-206
• 11 Hausberg M, Mann J, Kühn K. Nieren und Hochdruck.  Dtsch Med Wochenschrift. 2008;  133 1853-1856
• 12 Hyman D J, Pavlik V N. Characteristics of patients with uncontrolled hypertension in the United States.  N Engl J Med. 2001;  345 479-86
• 13 Jackson K C, Sheng X, Nelson R E, Keskinasian A, Brixner D I. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database.  Clin Ther. 2008;  30 1558-63
• 14 Lehnert H, Scholz T, Schäfer M, Klose S. Endokrine Hochdruckformen.  Dtsch Med Wochenschrift. 2007;  132 207-217
• 15 Lloyd-Jones D M, Evans J C, Larson M G, O’Donnel C J, Rocella E J, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community.  Hypertension. 2000;  36 594-599
• 16 Mann J F, Schmieder R E, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsärinne K, Oto A, Parkhomenko A, Piegas L S, Svendsen T L, Teo K K, Yusuf S. ONTARGET investigators . Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.  Lancet. 2008;  372 547-53
• 17 Mann S J. Severe paroxysmal hypertension (pseudopheochromocytoma).  Arch Intern Med. 1999;  159 670-4
• 18 Moser M, Setaro J F. Resistant or difficult-to-control hypertension.  N Engl J Med. 2006;  355 385-92
• 19 Nuesch R, Schroeder K, Dieterle T, Benedeict M, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study.  BMJ. 2001;  323 142-146
• 20 Oparil S, Calhoun D A. Managing the patient with hard-to-control hypertension.  Am Fam Physician. 1998;  57 1007-14
• 21 Sarafidis P A, Bakris G L. Resistant hypertension: an overview of evaluation and treatment.  J Am Coll Cardiol. 2008;  52 1749-57
• 22 Vinker S, Alkalay A, Hoffman R D, Elhaynay A, Kaiserman I, Kitai E. Long-term adherence to antihypertensive therapy: a survey in four primary care clinics.  Expert Opin Pharmacother. 2008;  9 1271-7
• 23 Zeller A, Schroeder K, Peters T J. Alectronic pillboxes (MEMS) to assess the relationship between medication adherence and blood pressure control in primary care.  Scand J Prim Health Care. 2007;  25 2002-7